These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Williamson LM; Hackett G; Rennie J; Palmer CR; Maciver C; Hadfield R; Hughes D; Jobson S; Ouwehand WH Blood; 1998 Oct; 92(7):2280-7. PubMed ID: 9746765 [TBL] [Abstract][Full Text] [Related]
3. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Ghevaert C; Campbell K; Walton J; Smith GA; Allen D; Williamson LM; Ouwehand WH; Ranasinghe E Transfusion; 2007 May; 47(5):901-10. PubMed ID: 17465957 [TBL] [Abstract][Full Text] [Related]
4. The management of alloimmune neonatal thrombocytopenia. Blanchette VS; Johnson J; Rand M Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040 [TBL] [Abstract][Full Text] [Related]
5. Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GPIIIa-Gln489). Westman P; Hashemi-Tavoularis S; Blanchette V; Kekomäki S; Laes M; Porcelijn L; Kekomäki R Tissue Antigens; 1997 Aug; 50(2):113-8. PubMed ID: 9271820 [TBL] [Abstract][Full Text] [Related]
6. Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study. Doughty HA; Murphy MF; Metcalfe P; Waters AH Br J Haematol; 1995 Jun; 90(2):321-5. PubMed ID: 7794750 [TBL] [Abstract][Full Text] [Related]
7. Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland. Davoren A; McParland P; Crowley J; Barnes A; Kelly G; Murphy WG BJOG; 2003 May; 110(5):492-6. PubMed ID: 12742334 [TBL] [Abstract][Full Text] [Related]
8. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families. Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia. de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048 [TBL] [Abstract][Full Text] [Related]
10. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a. Boehlen F; Kaplan C; de Moerloose P Vox Sang; 1998; 74(3):201-4. PubMed ID: 9595650 [TBL] [Abstract][Full Text] [Related]
11. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women. Kjeldsen-Kragh J; Bengtsson J Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264 [TBL] [Abstract][Full Text] [Related]
12. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Turner ML; Bessos H; Fagge T; Harkness M; Rentoul F; Seymour J; Wilson D; Gray I; Ahya R; Cairns J; Urbaniak S Transfusion; 2005 Dec; 45(12):1945-56. PubMed ID: 16371049 [TBL] [Abstract][Full Text] [Related]
13. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61. Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A; BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555 [TBL] [Abstract][Full Text] [Related]
14. What's happening? The expanding role of apheresis platelet support in neonatal alloimmune thrombocytopenia: current status and future trends. Bessos H; Seghatchian J Transfus Apher Sci; 2005 Oct; 33(2):191-7. PubMed ID: 16140039 [TBL] [Abstract][Full Text] [Related]
15. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele. Smith GA; Rankin A; Riddle C; Cheetham-Wilkinson C; Ranasinghe E; Ouwehand WH; Watkins NA Vox Sang; 2007 Nov; 93(4):325-30. PubMed ID: 18070277 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia. Sainio S; Javela K; Tuimala J; Koskinen S Transfus Med; 2013 Apr; 23(2):114-20. PubMed ID: 23448161 [TBL] [Abstract][Full Text] [Related]
17. The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations. Valentin N; Gagne K; Kerdudou N; Hallé L; Kaplan C; Killie MK; Skogen B; Muller JY; Bignon JD Transfusion; 2007 Dec; 47(12):2322-9. PubMed ID: 17714418 [TBL] [Abstract][Full Text] [Related]
18. Antenatal diagnosis and management of fetomaternal alloimmune thrombocytopenia. Dickinson JE; Marshall LR; Phillips JM; Barr AL Am J Perinatol; 1995 Sep; 12(5):333-5. PubMed ID: 8540936 [TBL] [Abstract][Full Text] [Related]
19. The natural history of maternal immunization against foetal platelet alloantigens. Ohto H; Miura S; Ariga H; Ishii T; Fujimori K; Morita S; Transfus Med; 2004 Dec; 14(6):399-408. PubMed ID: 15569234 [TBL] [Abstract][Full Text] [Related]
20. Neonatal thrombocytopenia in HLA-DR, -DQ, -DP-typed mother due to rare anti-HPA-1b (PLA2) (Zwb) fetomaternal immunization. Mercier P; Chicheportiche C; Reviron D; Dabanian C; Bourgue F; Chiaroni J; Diallo M; Delord Y Vox Sang; 1994; 67(1):46-51. PubMed ID: 7975452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]